FLCE
Exchange-traded product on NYSE (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Jul 31, 2026
The full portfolio as of the quarter end Jul 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Sep 28, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Apr 30, 2026.
7 lines, 7 linked, weights sum to 99.77% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| T Rowe Price US Equity Research ETF | US87283Q5036 | Fund | 441,708 | +32,528 | 25.92% | $ 20.813M |
| iShares US Equity Factor ETF | US46434V2824 | Fund | 200,671 | +14,782 | 19.02% | $ 15.271M |
| JPMorgan Active Value ETF | US46641Q1673 | Fund | 155,000 | +11,419 | 15.74% | $ 12.642M |
| Vanguard Dividend Appreciation Index Fund | US9219088443 | Fund | 40,338 | +2,964 | 12.01% | $ 9.648M |
| T Rowe Price Capital Appreciation Equity ETF | US87283Q8675 | Fund | 217,972 | +16,055 | 11.26% | $ 9.044M |
| JPMorgan Active Growth ETF | US46654Q6098 | Fund | 93,330 | +6,878 | 10.66% | $ 8.556M |
| GMO US Quality ETF | US90139K1007 | Fund | 99,301 | +7,315 | 5.17% | $ 4.149M |